EU follows U.S. in backing Sanofi, Regeneron eczema drug
July 21, 2017 at 07:30 AM EDT
LONDON, July 21 (Reuters) - The European Medicines Agency on Friday recommended approval of Regeneron Pharmaceuticals and Sanofi's new drug Dupixent for atopic dermatitis, a product many analysts see as the most important growth driver for the two companies.